Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury

被引:22
|
作者
Yamamoto, Yasuhiko [1 ]
Yamamoto, Hiroshi [1 ]
机构
[1] Kanazawa Univ, Grad Sch Med Sci, Dept Biochem & Mol Vasc Biol, Kanazawa, Ishikawa 9208640, Japan
关键词
STRESS; RAGE;
D O I
10.1038/ki.2012.163
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic kidney disease (CKD) is characterized by progressive decline in renal function. Podocyte dropouts contribute to the pathogenesis of diabetic and nondiabetic CKD. Zhou and colleagues demonstrate that the association between advanced oxidation protein products (AOPPs) and receptor for advanced glycation end products (RAGE) elicited podocyte injuries, using cultured podocytes and mice injected with AOPPs. This study suggests that the blockade of RAGE is preventive and therapeutic against podocyte apoptosis caused by oxidative stress-related AOPPs in CKD. Kidney International (2012) 82, 733-735. doi:10.1038/ki.2012.163
引用
收藏
页码:733 / 735
页数:4
相关论文
共 50 条
  • [21] Understanding RAGE, the receptor for advanced glycation end products
    Bierhaus, A
    Humpert, PM
    Morcos, M
    Wendt, T
    Chavakis, T
    Arnold, B
    Stern, DM
    Nawroth, PP
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11): : 876 - 886
  • [22] The Receptor for Advanced Glycation End Products (RAGE) and the Lung
    Buckley, Stephen T.
    Ehrhardt, Carsten
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2010,
  • [23] Participation of the Receptor for Advanced Glycation End Products in Efferocytosis
    Friggeri, Arnaud
    Banerjee, Sami
    Biswas, Subrata
    de Freitas, Andressa
    Liu, Gang
    Bierhaus, Angelika
    Abraham, Edward
    JOURNAL OF IMMUNOLOGY, 2011, 186 (11): : 6191 - 6198
  • [24] Signal Diversity of Receptor for Advanced Glycation End Products
    Sakaguchi, Masakiyo
    Kinoshita, Rie
    Putranto, Endy Widya
    Ruma, I. Made Winarsa
    Sumardika, I. Wayan
    Youyi, Chen
    Tomonobu, Naoko
    Yamamoto, Ken-ichi
    Murata, Hitoshi
    ACTA MEDICA OKAYAMA, 2017, 71 (06) : 459 - 465
  • [25] Understanding RAGE, the receptor for advanced glycation end products
    Angelika Bierhaus
    Per M. Humpert
    Michael Morcos
    Thoralf Wendt
    Triantafyllos Chavakis
    Bernd Arnold
    David M. Stern
    Peter P. Nawroth
    Journal of Molecular Medicine, 2005, 83 : 876 - 886
  • [26] Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)
    Oldfield, MD
    Bach, LA
    Forbes, JM
    Nikolic-Paterson, D
    McRobert, A
    Thallas, V
    Atkins, RC
    Osicka, T
    Jerums, G
    Cooper, ME
    JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (12): : 1853 - 1863
  • [27] Modulation of soluble receptor for advanced glycation end products isoforms and advanced glycation end products in long-living individuals
    Scavello, Francesco
    Tedesco, Calogero C.
    Castiglione, Stefania
    Maciag, Anna
    Sangalli, Elena
    Veglia, Fabrizio
    Spinetti, Gaia
    Puca, Annibale A.
    Raucci, Angela
    BIOMARKERS IN MEDICINE, 2021, 15 (11) : 785 - 796
  • [28] Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products and Risk of Colorectal Cancer - A Prospective Cohort Study
    Jiao, Li
    Albanes, Demetrius
    Weinstein, Stephanie J.
    Graubard, Barry I.
    Taylor, Philip R.
    Virtamo, Jarmo
    Stolzenberg-Solomon, Rachael
    GASTROENTEROLOGY, 2010, 138 (05) : S18 - S18
  • [29] Receptor for advanced glycation end products (RAGE) and acute lung injury (ALI)
    Izushi, Yasuhisa
    Wake, Hidenori
    Liu, Keyue
    Takahasi, Hideo
    Mori, Shuji
    Nishibori, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 206P - 206P
  • [30] The receptor for advanced glycation end products in ventilator-induced lung injury
    Kuipers M.T.
    Aslami H.
    Tuinman P.R.
    Tuip-De Boer A.M.
    Jongsma G.
    van der Sluijs K.F.
    Choi G.
    Wolthuis E.K.
    Roelofs J.J.T.H.
    Bresser P.
    Schultz M.J.
    van der Poll T.
    Wieland C.W.
    Intensive Care Medicine Experimental, 2 (1) : 1 - 13